Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.44 USD | +43.07% | +49.57% | +59.27% |
Chart calendar iTeos Therapeutics, Inc.
Upcoming events on iTeos Therapeutics, Inc.
Past events on iTeos Therapeutics, Inc.
2024-05-10 08:26 am | Q1 2024 Earnings Release |
2024-04-07 04:30 pm | American Association for Cancer Research Meeting - Abstract No - 734 |
2024-03-10 | Leerink Partners Global Biopharma Conference |
2024-03-06 01:30 pm | TD Cowen Health Care Conference |
2024-03-06 07:00 am | Q4 2023 Earnings Release |
2024-01-10 06:00 pm | JPMorgan Healthcare Conference |
2023-11-28 01:30 pm | Piper Sandler Healthcare Conference - Fireside Chat |
2023-11-07 07:00 am | Q3 2023 Earnings Release |
2023-09-27 08:35 am | Cantor Global Healthcare Conference |
2023-09-13 12:30 pm | H.C. Wainwright Global Investment Conference |
2023-08-08 07:00 am | Q2 2023 Earnings Release |
2023-06-13 09:00 am | Annual General Meeting |
2023-05-10 07:01 am | Q1 2023 Earnings Release |
2023-04-13 | American Association for Cancer Research Meeting - Poster No - EOS-850 |
2023-03-15 07:00 am | Q4 2022 Earnings Release |
2023-03-07 09:10 am | Cowen Health Care Conference |
2023-02-14 10:00 am | SVB Securities Global Biopharma Conference |
2023-01-10 11:15 am | JP Morgan Healthcare Conference |
2022-11-29 04:30 pm | Piper Sandler Healthcare Conference |
2022-11-10 04:01 pm | Q3 2022 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 345 190 81.72% | 268 258 3.57% | 12,6 20,1 -37.27% | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -44,7 -45,0 0.66% | 246 124 97.94% | 127 118 7.73% | 0,00 0,00 - | -196 |
EBIT Million USD | Released Forecast Spread | -28,0 | -45,2 -46,1 1.8% | 245 91,6 167.33% | 126 109 15.66% | -151 -144 -5.04% | -202 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -38,1 -40,9 6.82% | 256 88,6 189.31% | 149 126 17.73% | -109 -113 3.58% | -156 |
Net income Million USD | Released Forecast Spread | -22,5 | -43,4 -43,1 -0.67% | 215 77,5 176.86% | 96,7 90,4 6.93% | -113 -124 9.22% | -158 |
EPS USD | Released Forecast Spread | 0,00 | -2,88 -2,35 -22.74% | 5,68 2,09 171.56% | 2,56 2,40 6.83% | -3,15 -3,40 7.47% | -4,08 |
Announcement Date | 22/05/20 | 24/03/21 | 23/03/22 | 15/03/23 | 06/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 153 63,3 140.95% | 41,7 85,6 -51.25% | 19,5 41,6 -53.2% | 53,9 40,9 31.72% | 12,6 6,90 82.57% | 0,00 0,00 - | 0,00 0,00 - | 0,00 7,40 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBITDA Million USD | Released Forecast Spread | 3,53 4,00 -11.75% | -15,0 -1,00 -1400% | 17,6 -6,00 393.43% | -24,7 -38,0 34.98% | -42,4 -39,0 -8.71% | -43,1 -44,0 2.15% | -46,0 | -50,0 | -53,0 | |||||
EBIT Million USD | Released Forecast Spread | 121 23,9 404.77% | 3,34 40,8 -91.83% | -15,2 0,73 -2169.41% | 17,4 -3,47 601.13% | -24,9 -30,2 17.38% | -42,6 -39,8 -7.06% | -43,3 -45,1 3.93% | -40,1 -33,0 -21.58% | -47,2 -44,3 -6.59% | -48,7 | -51,8 | -55,2 | -64,8 | -66,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 120 30,6 290.11% | 8,44 40,8 -79.31% | -1,99 3,50 -156.73% | 22,7 1,56 1358.78% | -14,4 -26,2 45.19% | -33,1 -32,6 -1.58% | -33,4 -38,2 12.57% | -28,2 -28,4 0.75% | -36,0 -36,8 2.07% | -37,8 | -39,9 | -43,1 | -55,0 | -56,1 |
Net income Million USD | Released Forecast Spread | 69,6 30,3 129.71% | 5,63 46,2 -87.83% | 0,99 2,46 -59.7% | 20,5 5,48 273.52% | -15,6 -35,1 55.65% | -34,3 -36,9 7.15% | -32,2 -43,1 25.2% | -30,6 -37,7 19.02% | -38,2 -36,8 -3.95% | -37,8 | -39,9 | -43,1 | -55,0 | -56,1 |
EPS USD | Released Forecast Spread | 1,82 0,80 128.93% | 0,15 1,20 -87.53% | 0,03 0,07 -59.37% | 0,55 0,13 332.36% | -0,44 -0,99 55.74% | -0,96 -1,03 6.84% | -0,90 -1,20 25.25% | -0,85 -1,03 17.73% | -1,07 -1,02 -4.99% | -1,00 | -0,99 | -1,07 | -1,45 | -1,56 |
Announcement Date | 12/05/22 | 10/08/22 | 10/11/22 | 15/03/23 | 10/05/23 | 08/08/23 | 07/11/23 | 06/03/24 | 10/05/24 | - | - | - | - | - |
2024-05-13 | IMMATICS N.V.: Q1 2024 Earnings Release (Projected) |
2024-05-13 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-13 | PEPTIDREAM INC.: Q1 2024 Earnings Release |
2024-05-13 | NYKODE THERAPEUTICS: Q1 2024 Earnings Release |
2024-05-13 | ABL BIO INC.: Q1 2024 Earnings Release (Projected) |
2024-05-13 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release (Projected) |
2024-05-14 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-14 | CELCUITY INC.: Q1 2024 Earnings Release |
2024-05-15 | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 09:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
Past sector events for iTeos Therapeutics, Inc.
Today | PHARMAESSENTIA CORPORATION: Q1 2024 Earnings Release |
Today | ALLOGENE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Today | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q1 2024 Earnings Release (Projected) |
Today | LEGEND BIOTECH CORPORATION: Q1 2024 Earnings Release |
Today | PEPTRON, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-10 04:02 pm | CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release |
2024-05-10 08:26 am | ITEOS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-10 08:00 am | PRIME MEDICINE, INC.: Q1 2024 Earnings Release |
2024-05-10 07:00 am | AKERO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-09 08:05 pm | SOLENO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ITOS Stock
- Calendar iTeos Therapeutics, Inc.